Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia



Status:Completed
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - 80
Updated:4/2/2016
Start Date:September 2000
End Date:August 2005
Contact:Roopa R Chakkappan, M.P.H
Email:roopa.chakkappan@downtownhospital.org
Phone:212-312-5268

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)

To determine if the use of oral Diindolylmethante (DIM), a marketed cruciferous vegetable
based dietary supplement (Bioresponse-DIM), is associated with the regression of cervical
dysplasia in otherwise healthy women.

To determine if the use of oral Diindolylmethane (DIM), a marketed cruciferous vegetable
based dietary supplement (BioResponse-DIM®), is associated with the regression of cervical
dysplasia in otherwise healthy women. Additionally, the study aims to see how the use of the
BioResponse-DIM supplement correlates with cervical HPV colonization, and to asses the
tolerability of daily DIM supplementation

Inclusion Criteria:

- Non pregnant women greater than or equal to 18 years of age able to consent

- CIN II or III confirmed by histology

- Karnofsky performance status >= 80

- No prior treatment for dysplasia in the past 4 months

Exclusion Criteria:

- Incompletely visible lesion

- Diethylstilbestrol (DES) exposure

- HIV seropositive
We found this trial at
1
site
NYU School of Medicine
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials